Oscar the Grouch (James Devaney/Getty Images)

Oscar Health is the newest retail stock market darling, with shares up 60% this week

Shares of the telehealth company are up nearly 60% this week on no news and lots of love from retail traders.

6/20/25 9:45AM

Oscar Health started the week as a $3.6 billion health insurance company, and it’s poised to add about $2 billion to its market cap by the weekend despite a dearth of any apparent fundamental catalysts for the stock.

So, what does Oscar have going for it?

Its top line has been growing quite fast: revenues were up 48% in 2023 and 57% in 2024, which has translated into propelled adjusted earnings per share turning up to a peak of $0.92 in Q1 2025.
It’s a health insurance company that also bills itself as a “tech” company, continuing a long-standing tradition where executives try to tie themselves to an industry that typically commands higher valuations. Of note: Oscar hails its “continuous hackathon” approach of applying AI to health insurance.
The vice chairman of the board, Joshua Kushner, is the younger brother of Jared Kushner — and as we’ve seen in the run-up to and aftermath of the 2024 election, it hasn’t hurt to have decent relationships with the people in or surrounding this administration.

But what does Oscar really have going for it?

It’s a new retail trading darling. The stock is one of the most mentioned on the r/WallStreetBets subreddit, per SwaggyStocks.
On a related note, volumes have exploded. Nearly 50 million shares changed hands on Wednesday, the second-highest in the company’s history.
Similarly, options activity has gone gangbusters, with call volumes hitting a record 152,414 on Wednesday and another 95,000 on Friday as of 10:30 a.m. ET, nearly triple the 20-day average of 33,708.

Anywho, we’re about $3 away from welcoming another Oscar to the world thanks to the stock’s surge. This one probably won’t live in a trash can.

Nia Warfield

31m

Six Flags pops after reiterating its guidance as theme park attendance rebounds

Six Flags shares rose more than 7% today after the company reported a rebound in attendance and early season-pass sales heading into the fall. The nine-week period ending August 31 saw 17.8 million guests, up about 2% from the same stretch in 2024, with stronger momentum in the final four weeks.

More importantly, Six Flags reaffirmed its full-year adjusted EBITDA guidance of $860 million to $910 million, showing confidence that its cost and operations strategy can stay strong for the duration of the year. Riding that wave, Six Flags also said early 2026 season pass unit sales are pacing ahead of last year, and average season pass prices are up around 3%.

The good vibes come despite a drop in in-park per capita spending, especially from admissions, where promotions and changes to attendance mix (which parks or days guests visit) have weighed. Earlier this week, the amusement giant extended a new agreement that extended its position as the exclusive amusement park partner for Peanuts™ in North America through 2030.

Despite the rally, Six Flags shares are down around 52% year-to-date.

Max Knoblauch

Rivian turns red on the year, squeezed by a recall and the looming end of the EV tax credit

Shares of EV maker Rivian are down more than 5% on Friday following the company’s recall of 24,214 vehicles due to a software issue. The stock move erases Rivian’s year-to-date gain and turns the company negative on the year.

Rivian’s 2025 model year R1S and R1T are affected by the defect, which was identified after a vehicle’s hands-free highway assist software failed to identify another vehicle on the road, causing a low-speed collision. Rivian said it’s released an over-the-air update to fix the issue.

The recall marks Rivian’s fifth this year, affecting nearly 70,000 of its vehicles.

Rivian’s shares are down more than 20% from their 2025 high, which came prior to the passage of President Trump’s “big, beautiful bill.” Through the legislation, the $7,500 EV tax credit is set to expire at the end of the month.

J. Edward Moreno

Moderna, Pfizer dip after WaPo reports Trump officials’ plan to link Covid vaccines to child deaths

Vaccine makers are falling after The Washington Post reported that the Trump administration plans to link the coronavirus vaccine to 25 child deaths.

Moderna and Pfizer, the two companies who sell the vaccine in the US, fell by more than 5% and 2%, respectively. The coronavirus vaccine is virtually the only revenue driver for Moderna, while Pfizer has a larger and more diverse portfolio.

Trump officials to link child deaths to covid shots, alarming career scientists

Hyunsoo Rim

DEVELOPING PROBLEMS

Concerns about rising government debt are not strictly an American problem

Global government debt piles are swelling to record levels. That’s an issue for many nations, but developing countries may be most at risk.

Closeup rolled of variety banknote and multi currency around the world. Exchange rate and Forex investment concept.-Image.

Nia Warfield

RH slips after missing Q2 estimates and trimming its outlook amid cost pressure

Restoration Hardware shares dropped Friday morning after the luxury furniture brand missed Q2 estimates and tightened its full-year outlook.

Adjusted earnings per share came in at $2.93, below the Street’s estimate of $3.21. Revenue was $899.2 million, also missing analysts’ forecast of $905 million.

RH now expects full-year revenue growth of 9% to 11%, down from prior guidance of 10% to 13%, as margins get squeezed by tariffs and weakness in the housing market. Wall Street had been looking for about 10% growth this year.

The retailer is taking steps to blunt cost pressures, including shifting sourcing away from China. RH expects receipts to fall from 16% in Q1 to 2% in Q4, with vendors absorbing a meaningful portion of the tariff impact. RH is also boosting US manufacturing capacity in North Carolina and pushing back a new concept launch to next spring.

RH shares are down about 43% year to date.